• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Ex-accountant sues SpineFrontier

Ex-accountant sues SpineFrontier

May 28, 2015 By Brad Perriello

Ex-accountant sues SpineFrontier

A former accountant for SpineFrontier sued the company this month for wrongful termination, alleging that the spinal implant maker fired her for raising concerns about manufacturing processes later flagged by the FDA in a warning letter.

Patricia Katz was hired by Beverly, Mass.-based SpineFrontier as a senior accountant in February 2011, according to court documents. But soon after her employment began, "Katz voiced concern about SpineFrontier’s lot tracking and tracing procedures, which involved little to no tracking," she alleged in a lawsuit filed in the U.S. District Court for Massachusetts.

After her immediate supervisor dismissed her concerns, and with a pair of compliance classes under her belt, Katz allegedly "learned that SpineFrontier’s lot tracking and tracing procedures violated federal safety regulations for medical devices" and subsequently opened a Corrective & Preventive Action report documenting the deficiencies.

"But when Katz opened a CAPA for SpineFrontier’s lot recording deficiencies, the company’s chief innovation officer promptly closed it," the lawsuit alleged.

After confirming her suspicions with the FDA, without naming SpineFrontier, Katz forwarded her correspondence with an FDA agent to company officials, she alleged. After a meeting scheduled while she was out of the office to attend to her ill father, she alleged, she was fired on her 1st day back at work.

"Soon after her termination, Katz contacted the FDA by phone to report the violations, later following up with a letter. When the FDA investigated, it found rampant problems with tracking, tracing, design and inspection safeguards, and handling of adverse event investigation and reporting, leading to a formal, public warning letter that designated the company’s devices as adulterated and misbranded for 9 types of violations," according to the lawsuit.

"SpineFrontier knew that its devices were misbranded and adulterated, but marketed and sold them anyway despite the prohibitions of federal law," Katz alleged. "When it became clear to SpineFrontier that Katz would not let the matter drop and that she was willing to speak with the FDA about it, she was immediately terminated."

SpineFrontier denied the accusations, according to the documents, and argued that the case should be dismissed for failure to state a claim, lapsed statute of limitations, laches and the doctrine of unclean hands.

"The claim is barred by the plaintiffs’ own negligence, fraud, or unfair and deceptive conduct," SpineFrontier alleged.

Filed Under: Food & Drug Administration (FDA), Legal News, News Well, Orthopedics Tagged With: SpineFrontier

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy